This brand-new trial comes after in the custom of three prior landmark trials: MADIT.

Boston Scientific begins individual enrollments for MADIT-RIT clinical trial Boston Scientific Company today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This brand-new trial comes after in the custom of three prior landmark trials: MADIT, MADIT MADIT-CRT and II, each specifically sponsored by Boston Scientific and carried out beneath the leadership of Principal Investigator Arthur J. Moss, M inside lungs .D., Professor of Medication at the University of Rochester.